US4367335A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Thiazolidinylalkylene piperazine derivatives
Assignee: Mead Johnson and Co LLC
•
Filing: 1981-08-03
•
Granted: 1983-01-04
•
Expires: 2001-08-03
Abstract
Abstract Piperazinyl derivatives containing a 3-alkylene-2,4-thiazolidinedione heterocyclic component with relatively selective psychotropic properties are disclosed. The compound 3-[4-[4-(2-pyrimidinyl)-1-piperazinyl]butyl]-2,4-thiazolidinedione which has selective anxiolytic activity constitutes a typical embodiment of the invention.
Inventors
- 👤 Davis L. Temple, Jr.
- 👤 Richard E. Yeager
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-06 12:13
CPC Classifications
C; C07; C07D; C07D417/00; C07D417/02; C07D417/12; A; A61; A61P; A61P25/00; A61P25/18; A61P25/20; C07D277/00; C07D277/02; C07D277/20; C07D277/32; C07D277/34
Claims Analysis
Total Claims: 15
Claim 1
Independent Claim
108 words
A thiazolidinedione having Formula I ##STR14## wherein R 1 is hydrogen or lower alkyl of 1 to 4 carbon atoms, n is the integer 2 through 5, Z is a R 2 -substituted phenyl radical having the formula ##STR15## in which R 2 is hydrogen, halogen, lower alkyl of 1 to 4 carbon atoms, lower alkoxy of 1 to 4 carbon atoms or trifluoromethyl, with the proviso that when n is 3 , 4 or 5, Z is also 2-pyrimidinyl or a R 3 -substituted 2-pyridinyl radical having the formula ##STR16## in which R 3 is hydrogen or cyano or a pharmaceutically acceptable non-toxic acid addition salt thereof.
Claim 2
Dependent Claim
108 words
A thiazolidinedione having Formula I ##STR14## wherein R 1 is hydrogen or lower alkyl of 1 to 4 carbon atoms, n is the integer 2 through 5, Z is a R 2 -substituted phenyl radical having the formula ##STR15## in which R 2 is hydrogen, halogen, lower alkyl of 1 to 4 carbon atoms, lower alkoxy of 1 to 4 carbon atoms or trifluoromethyl, with the proviso that when n is 3 , 4 or 5, Z is also 2-pyrimidinyl or a R 3 -substituted 2-pyridinyl radical having the formula ##STR16## in which R 3 is hydrogen or cyano or a pharmaceutically acceptable non-toxic acid addition salt thereof.
Claim 3
Dependent Claim
16 words
The compound of claim 1 which is 3-[4-[4-[3-(trifluoromethyl)phenyl]-1-piperazinyl]butyl]-2,4-thiazolidinedione or a pharmaceutically acceptable acid addition salt thereof.
Claim 4
Dependent Claim
16 words
The compound of claim 1 which is 3-[4-[4-(3-chlorophenyl)-1-piperazinyl]butyl]-2,4-thiazolidinedione or a pharmaceutically acceptable acid addition salt thereof.
Claim 5
Dependent Claim
16 words
The compound of claim 1 which is 3-[4-[4-(2-methoxyphenyl)-1-piperazinyl]butyl]-2,4-thiazolidinedione or a pharmaceutically acceptable acid addition salt thereof.
Claim 6
Dependent Claim
16 words
The compound of claim 1 which is 3-[4-[4-(2-pyrimidinyl)-1-piperazinyl]butyl]-2,4-thiazolidinedione or a pharmaceutically acceptable acid addition salt thereof.
Claim 7
Dependent Claim
16 words
The compound of claim 1 which is 3-[4-[4-(2-pyridinyl)-1-piperazinyl]butyl]-2,4-thiazolidinedione or a pharmaceutically acceptable acid addition salt thereof.
Claim 8
Dependent Claim
16 words
The compound of claim 1 which is 2-[4-[4-(2,4-dioxothiazolidin-3-yl]butyl)-1-piperazinyl]pyridine-3-carbonitrile or a pharmaceutically acceptable acid addition salt thereof.
Claim 9
Dependent Claim
16 words
The compound of claim 1 which is 3-[4-[4-(3-chlorophenyl)-1-piperazinyl]butyl]-5-propyl-2,4-thiazolidinedione or a pharmaceutically acceptable acid addition salt thereof.
Claim 10
Dependent Claim
16 words
The compound of claim 1 which is 3-[3-[4-(3-chlorophenyl)-1-piperazinyl]propyl]-2,4-thiazolidinedione or a pharmaceutically acceptable acid addition salt thereof.
Claim 11
Dependent Claim
16 words
The compound of claim 1 which is 3-[3-[4-[3-trifluoromethyl)phenyl]-1-piperazinyl]propyl]-2,4-thiazolidinedione or a pharmaceutically acceptable acid addition salt thereof.
Claim 12
Dependent Claim
16 words
The compond of claim 1 which is 3-[3-[4-(2-methoxyphenyl)-1-piperazinyl]propyl]-2,4-thiazolidinedione or a pharmaceutically acceptable acid addition salt thereof.
Claim 13
Dependent Claim
16 words
The compound of claim 1 which is 3-[3-[4-(2-pyrimidinyl)-1-piperazinyl]propyl]-2,4-thiazolidinedione or a pharmaceutically acceptable acid addition salt thereof.
Claim 14
Dependent Claim
16 words
The compound of claim 1 which is 2-[4-[3-(2,4-dioxothiazolidin-3-yl)propyl-1-piperazinyl]pyridine-3-carbonitrile or a pharmaceutically acceptable acid addition salt thereof.
Claim 15
Dependent Claim
16 words
The compound of claim 1 which is 3-[2-[4-(3-chlorophenyl)-1-piperazinyl]ethyl]-2,4-thiazolidinedione or a pharmaceutically acceptable acid addition salt thereof.
References Cited (Backward Citations)
US2672460A
Cited
US2748125A
Cited
US3398151A
Cited
US4060526A
Cited
US3822266A
Cited
US3717634A
Cited
US3857845A
Cited
US3976776A
Cited
US4017622A
Cited
US3941789A
Cited
US3919230A
Cited
US4029790A
Cited
US3940398A
Cited
US4026894A
Cited
US4060615A
Cited
US4001237A
Cited
US4112092A
Cited
US4078063A
Cited
US4101548A
Cited
US4196206A
Cited
US4216216A
Cited
US4138561A
Cited
US4267178A
Cited
US4182763A
Cited
GB2023594A
Cited
US4161595A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1986-01-03 | 1986-07-05 | 1987-01-04 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1990-01-03 | 1990-07-05 | 1991-01-04 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1994-01-03 | 1994-07-05 | 1995-01-04 | $7700.00 | Window Closed / Lapsed |